Intravenous immunoglobulin therapy for resistant ocular behçet's disease

N. Seider; I. Beiran; J. Scharf; B. Miller

doi:10.1136/bjo.85.11.1287

Intravenous immunoglobulin therapy for resistant ocular behçet's disease

N. Seider, I. Beiran, J. Scharf, B. Miller

Research output: Contribution to journal › Article › peer-review

Abstract

Aims - The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular Behçet's disease (BD) refractory to accepted medical therapy. Methods - Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results - All six eyes of all four patients showed good response to gammaglobulin therapy. Conclusion - Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to substantiate this impression.

Original language	English
Pages (from-to)	1287-1288
Number of pages	2
Journal	British Journal of Ophthalmology
Volume	85
Issue number	11
DOIs	https://doi.org/10.1136/bjo.85.11.1287
State	Published - 2001
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology
Sensory Systems
Cellular and Molecular Neuroscience

Access to Document

10.1136/bjo.85.11.1287

Cite this

@article{c6ce1182376742b195a0f937a1bdb636,

title = "Intravenous immunoglobulin therapy for resistant ocular beh{\c c}et's disease",

abstract = "Aims - The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular Beh{\c c}et's disease (BD) refractory to accepted medical therapy. Methods - Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results - All six eyes of all four patients showed good response to gammaglobulin therapy. Conclusion - Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to substantiate this impression.",

author = "N. Seider and I. Beiran and J. Scharf and B. Miller",

year = "2001",

doi = "10.1136/bjo.85.11.1287",

language = "English",

volume = "85",

pages = "1287--1288",

journal = "British Journal of Ophthalmology",

issn = "0007-1161",

publisher = "BMJ Publishing Group",

number = "11",

}

TY - JOUR

T1 - Intravenous immunoglobulin therapy for resistant ocular behçet's disease

AU - Seider, N.

AU - Beiran, I.

AU - Scharf, J.

AU - Miller, B.

PY - 2001

Y1 - 2001

N2 - Aims - The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular Behçet's disease (BD) refractory to accepted medical therapy. Methods - Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results - All six eyes of all four patients showed good response to gammaglobulin therapy. Conclusion - Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to substantiate this impression.

AB - Aims - The present report was aimed at finding out whether gammaglobulin could have a role in treating ocular Behçet's disease (BD) refractory to accepted medical therapy. Methods - Six eyes of four patients with ocular BD refractory to steroids and cyclosporin A were treated with a course of intravenous gammaglobulin and followed up for their response to treatment. Results - All six eyes of all four patients showed good response to gammaglobulin therapy. Conclusion - Gamma globulin may have a role in treating refractory ocular BD. A wide range of controlled studies with longer follow up is needed to substantiate this impression.

UR - http://www.scopus.com/inward/record.url?scp=0034748411&partnerID=8YFLogxK

U2 - 10.1136/bjo.85.11.1287

DO - 10.1136/bjo.85.11.1287

M3 - Article

C2 - 11673289

AN - SCOPUS:0034748411

SN - 0007-1161

VL - 85

SP - 1287

EP - 1288

JO - British Journal of Ophthalmology

JF - British Journal of Ophthalmology

IS - 11

ER -

Intravenous immunoglobulin therapy for resistant ocular behçet's disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this